Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-07-02T10:01:03.018Z Has data issue: false hasContentIssue false

Chapter 13 - Tumors of the male urogenital system

Published online by Cambridge University Press:  05 November 2015

By
Kirsten D. Mertz  and
Lukas Bubendorf
Edited by
John M. S. Bartlett ,
Abeer Shaaban  and
Fernando Schmitt
John M. S. Bartlett
Affiliation:
Ontario Institute for Cancer Research, Toronto
Abeer Shaaban
Affiliation:
Queen Elizabeth Hospital Birmingham
Fernando Schmitt
Affiliation:
University of Porto
Get access
Type
Chapter
Information
Molecular Pathology
A Practical Guide for the Surgical Pathologist and Cytopathologist
 , pp. 189 - 199
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beltran, H. and Rubin, M. A. New strategies in prostate cancer: translating genomics into the clinic. Clin Cancer Res 2013; 19(3): 517–23.CrossRefGoogle ScholarPubMed
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L., Ciatto, S., Nelen, V. et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med 2009; 360(13): 1320–8.CrossRefGoogle Scholar
Jhavar, S., Bartlett, J., Kovacs, G., Corbishley, C., Dearnaley, D., Eeles, R. et al. Biopsy tissue microarray study of Ki-67 expression in untreated, localized prostate cancer managed by active surveillance. Prostate Cancer P D 2009; 12(2): 143–7.CrossRefGoogle ScholarPubMed
Zellweger, T., Gunther, S., Zlobec, I., Savic, S., Sauter, G., Moch, H. et al. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer 2009; 124(9): 2116–23.CrossRefGoogle ScholarPubMed
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X. W. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005; 310(5748): 644–8.CrossRefGoogle ScholarPubMed
Prensner, J. R. and Chinnaiyan, A. M. Oncogenic gene fusions in epithelial carcinomas. Curr Opin Genet Dev 2009; 19(1): 82–91.CrossRefGoogle ScholarPubMed
Mertz, K. D., Horcic, M., Hailemariam, S., D'Antonio, A., Dirnhofer, S., Hartmann, A. et al. Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer. Hum Pathol 2013; 44(12): 2727–35.CrossRefGoogle ScholarPubMed
Berg, K. D., Vainer, B., Thomsen, F. B., Roder, M. A., Gerds, T. A., Toft, B. G. et al. ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer. Eur Urol 2014 Mar. 7 (e-pub ahead of print).CrossRefGoogle ScholarPubMed
Tomlins, S. A., Aubin, S. M., Siddiqui, J., Lonigro, R. J., Sefton-Miller, L., Miick, S. et al. Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med 2011; 3(94): 94ra72.CrossRefGoogle ScholarPubMed
Hessels, D. and Schalken, J. A. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol 2009; 6(5): 255–61.CrossRefGoogle ScholarPubMed
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G. et al. Cumulative association of five genetic variants with prostate cancer. New Engl J Med 2008; 358(9): 910–19.CrossRefGoogle ScholarPubMed
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H., Vickers, E., A'Hern, R. et al. Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer. Cancer Res 2009; 69(7): 2912–18.CrossRefGoogle ScholarPubMed
Hu, B., Rochefort, H. and Goldkorn, A. Circulating tumor cells in prostate cancer. Cancers 2013; 5(4): 1676–90.CrossRefGoogle ScholarPubMed
Duijvesz, D., Luider, T., Bangma, C. H. and Jenster, G. Exosomes as biomarker treasure chests for prostate cancer. Eur Urol 2011; 59(5): 823–31.CrossRefGoogle ScholarPubMed
Daling, J. R., Madeleine, M. M., Johnson, L. G., Schwartz, S. M., Shera, K. A., Wurscher, M. A. et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer 2005; 116(4): 606–16.CrossRefGoogle ScholarPubMed
Boublikova, L., Buchler, T., Stary, J., Abrahamova, J. and Trka, J. Molecular biology of testicular germ cell tumors: unique features awaiting clinical application. Crit Rev Oncol Hematol 2014; 89(3): 366–85.CrossRefGoogle ScholarPubMed
Kaufman, D. S., Shipley, W. U. and Feldman, A. S. Bladder cancer. Lancet 2009; 374(9685): 239–49.CrossRefGoogle ScholarPubMed
Cheng, L., Davidson, D. D., Maclennan, G. T., Williamson, S. R., Zhang, S., Koch, M. O. et al. The origins of urothelial carcinoma. Expert Rev Anticancer Ther 2010; 10(6): 865–80.CrossRefGoogle ScholarPubMed
Cheng, L., Zhang, S., MacLennan, G. T., Williamson, S. R., Lopez-Beltran, A. and Montironi, R. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol 2011; 42(4): 455–81.CrossRefGoogle ScholarPubMed
van der Kwast, T. H. and Bapat, B. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling. Curr Opin Urol 2009; 19(5): 516–21.CrossRefGoogle ScholarPubMed
Bubendorf, L. Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma – FISHing for the right catch. Acta Cytol 2011; 55(2): 113–19.CrossRefGoogle ScholarPubMed
Halling, K. C. and Kipp, B. R. Bladder cancer detection using FISH (UroVysion assay). Adv Anat Pathol 2008; 15(5): 279–86.CrossRefGoogle ScholarPubMed
Wild, P. J., Fuchs, T., Stoehr, R., Zimmermann, D., Frigerio, S., Padberg, B. et al. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev 2009; 18(6): 1798–806.CrossRefGoogle ScholarPubMed
Mitra, A. P. and Cote, R. J. Molecular screening for bladder cancer: progress and potential. Nat Rev Urol 2010; 7(1): 11–20.CrossRefGoogle ScholarPubMed
Netto, G. J. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet? Nat Rev Urol 2012; 9(1): 41–51.CrossRefGoogle Scholar
Mitra, A. P. and Cote, R. J. Molecular pathogenesis and diagnostics of bladder cancer. Ann Rev Pathol 2009; 4: 251–85.CrossRefGoogle ScholarPubMed
Stewart, G. D., O'Mahony, F. C., Powles, T., Riddick, A. C., Harrison, D. J. and Faratian, D. What can molecular pathology contribute to the management of renal cell carcinoma? Nat Rev Urol 2011; 8(5): 255–65.CrossRefGoogle Scholar
Hodge, J. C., Pearce, K. E., Wang, X., Wiktor, A. E., Oliveira, A. M. and Greipp, P. T. Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases. Mod Pathol 2014; 27(1): 113–27.CrossRefGoogle ScholarPubMed
Pavlovich, C. P. and Schmidt, L. S. Searching for the hereditary causes of renal-cell carcinoma. Nat Rev Cancer 2004; 4(5): 381–93.CrossRefGoogle ScholarPubMed
Verine, J., Pluvinage, A., Bousquet, G., Lehmann-Che, J., de Bazelaire, C., Soufir, N. et al. Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 2010; 58(5): 701–10.CrossRefGoogle ScholarPubMed
Linehan, W. M., Srinivasan, R. and Schmidt, L. S. The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 2010; 7(5): 277–85.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×